Prediction markets tied to clinical trials and drug approvals draw lawmakers’ ire
Summary
Lawmakers are questioning the Department of Health and Human Services regarding potential risks associated with prediction markets linked to clinical trials and drug approvals. Senators Angela Alsobrooks and Ron Wyden have formally requested details on what measures the agency is taking to address these concerns.
Sens. Angela Alsobrooks and Ron Wyden are asking what steps the Department of Health and Human Services has taken to mitigate risks from the markets.
Source: Read the full story at US Top News and Analysis
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.